Features | Partner Sites | Information | LinkXpress
Sign In
JIB
GLOBETECH PUBLISHING
GLOBETECH PUBLISHING

Single-Use Bioreactor Now Accommodates Wide Range of Working Volumes

By BiotechDaily International staff writers
Posted on 24 Jun 2013
Image: The UniVessel SU (right) can work in parallel with classical multiuse reaction bioreactor vessels (Photo courtesy of Sartorius Stedim Biotech).
Image: The UniVessel SU (right) can work in parallel with classical multiuse reaction bioreactor vessels (Photo courtesy of Sartorius Stedim Biotech).
Image: The UniVessel SU is preassembled and ready-to-use out of the box (Photo courtesy of Sartorius Stedim Biotech).
Image: The UniVessel SU is preassembled and ready-to-use out of the box (Photo courtesy of Sartorius Stedim Biotech).
The second generation of a highly regarded single-use bioreactor vessel with built-in pH and dissolved oxygen sensors suitable for work with mammalian, insect, and plant cell cultures was recently released for researchers in biopharmaceuticals and other life sciences.

The Sartorius Stedim Biotech (Aubagne, France) UniVessel SU is a single-use bioreactor with a choice of working volumes ranging from 0.6 to two liters. The vessel is made of USP class VI conforming polycarbonate and includes several ports for media addition, sampling, harvesting, as well as spare ports for insertion of classical sensors or other equipment. All tubing for media transfer is thermoweldable and features common Luer or MPC connectors for fast and easy connection to peripheral equipment.

Key features of the UniVessel SU are the single-use sensors for optical measurement of pH and dissolved oxygen (DO). The determination of pH and DO with the SENSOLUX system is based on fluorescence detection. Each UniVessel SU contains two sensor patches for pH and DO, respectively. The actual measurement is performed optically and noninvasively from outside the vessel. The sensor patches contain fluorescent dyes, which can be excited with light of a given wavelength. Optoelectronics integrated in the vessel holder transmit light of a particular wavelength to the sensor patches. In turn, they also transmit the luminescence response from the patches to a measuring amplifier. The sensor patches inside the UniVessel SU come precalibrated. Calibration data are located on the vessel label and can be transferred manually or by barcode reader to the calibration menu of the bioreactor controller. UniVessel SU is compatible with Sartorius BIOSTAT controllers and can also be operated with nearly any other brand of bioreactor controller.

Each UniVessel SU unit is irradiated prior to delivery and is preassembled and ready-to-use out of the box. It is designed to the same safety standards, which are required for classical multiuse bioreactors. The complete culture vessel is disposed after use, eliminating cleaning time, autoclaving, and reinstallation hassle as well as the risk of cross-contamination.

Related Links:
Sartorius Stedim Biotech




comments powered by Disqus

Channels

Genomics/Proteomics

view channel
Image: Diagram illustrates the innovative process that could lead to more effective drugs against influenza infection (Photo courtesy of the Hebrew University of Jerusalem).

Researchers Show How the Influenza Virus Blocks Natural Killer Cell Recognition

A team of molecular virologists has described how the influenza virus evolved a defense mechanism to protect it from attack by the immune system's natural killer (NK) cells. The recognition of pathogen-infected... Read more

Drug Discovery

view channel
Image: Synthetic ion transporters can induce apoptosis by facilitating chloride anion transport into cells (Photo courtesy of the University of Texas, Austin).

Experimental Drug Kills Cancer Cells by Interfering with Their Ion Transport Mechanism

An experimental anticancer drug induces cells to enter a molecular pathway leading to apoptosis by skewing their ion transport systems to greatly favor the influx of chloride anions. To promote development... Read more

Therapeutics

view channel
Image: Liver cells regenerated in mice treated with a new drug (right) compared with a control group (center) after partial liver removal. Healthy liver cells are shown at left (Photo courtesy of Marshall et al, 2014, the Journal of Experimental Medicine).

New Drug Triggers Liver Regeneration After Surgery

Investigators have revealed that an innovative complement inhibitor decreases complement-mediated liver cell death, and actually stimulates postsurgery liver regrowth in mice. Liver cancer often results... Read more

Business

view channel

Partnership Established to Decode Bowel Disease

23andMe (Mountain View, CA,USA), a personal genetics company, is collaborating with Pfizer, Inc. (New York, NY, USA), in which the companies will seek to enroll 10,000 people with inflammatory bowel disease (IBD) in a research project designed to explore the genetic factors associated with the onset, progression, severity,... Read more
 
Copyright © 2000-2014 Globetech Media. All rights reserved.